Lineage Cell Therapeutics, Inc.: Form 8-K, filed Oct 28, 2022
Filed with the SEC on Oct 28, 2022 and accepted by EDGAR at Oct 28, 2022, 17:20 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 3.02 Unregistered sale of equity
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-22-029887. Last ingested by Listed: Nov 13, 2026, 16:09 ET. Listed shows no prices and gives no investment advice.